TABLE 1.
Sample size (N) and weighted characteristics of young adults participants in NHANES 2007-2010
| ALL | ||
|---|---|---|
| N | Weighted | |
| Blood Cadmium (μg/L), GM (SE) | 2892 | 0.31 (0.01) |
| Blood Lead (μg/dL), GM (SE) | 2892 | 0.96 (0.02) |
| Age (Years), GM (SE) | 2892 | 28.93 (0.34) |
| BMI(kg/m2), GM (SE) | 2892 | 27.32 (0.18) |
| Serum Cotinine (ng/mL), GM (SE) | 2892 | 0.75 (0.11) |
| Sex | ||
| Men, % (SE) | 1439 | 51.38 (1.05) |
| Women, % (SE) | 1453 | 48.62 (1.05) |
| Depressive Symptoms | ||
| Yes, % (SE) | 287 | 7.85 (0.44) |
| No, % (SE) | 2605 | 92.15 (0.44) |
| Body Weight | ||
| Underweight/Normal weight, % (SE) | 1044 | 38.18 (1.58) |
| Overweight, % (SE) | 861 | 29.89 (0.89) |
| Obese, % (SE) | 987 | 31.93 (1.45) |
| Poverty Income Ratio | ||
| PIR (below or equal poverty line), % (SE) | 794 | 19.84 (1.18) |
| PIR (above poverty line), % (SE) | 2098 | 80.16 (1.18) |
| Smoking Status | ||
| Current Smokers (self-report and LBXCOT>3.00 ng/mL), % (SE) | 1093 | 37.15 (1.52) |
| Not-Current Smoker (Self-report Former and never smoker and lbxcot≥3ng/mL), % (SE) | 1799 | 62.85 (1.52) |
| Alcohol Consumption | ||
| No Alcohol, % (SE) | 615 | 18.31 (0.95) |
| 1-4 drinks per week, % (SE) | 1826 | 66.70 (1.51) |
| >4 drinks per week, % (SE) | 451 | 14.99 (1.11) |
| Education Level | ||
| Less than High School, % (SE) | 670 | 17.37 (1.14) |
| Completed High School, % (SE) | 689 | 21.89 (1.18) |
| More than High School, % (SE) | 1533 | 60.74 (1.90) |
| Race/ethnicity | ||
| White (Non-Hispanic), % (SE) | 1306 | 63.24 (2.92) |
| Non-Hispanic Black, % (SE) | 527 | 11.59 (1.19) |
| Hispanic, % (SE) | 896 | 18.12(2.21) |
| Other, % (SE) | 163 | 7.05 (0.82) |
| Blood Cadmium Quartile | ||
| BCd Q1 (Below limit of detection 0.20 μg/L), % (SE) | 833 | 31.44 (1.12) |
| BCd Q2 (0.20 – 0.27 μg/L), % (SE) | 640 | 22.19 (0.92) |
| BCd Q3 (0.28 – 0.54 μg/L), % (SE) | 719 | 23.74 (0.97) |
| BCd Q4 (>0.54 μg/L), % (SE) | 700 | 22.63 (1.36) |
| Blood Lead Quartile | ||
| BPb Q1 (≤ 0.63 μg/dL), % (SE) | 661 | 24.75 (1.16) |
| BPb Q2 (0.64 – 0.90 μg/dL), % (SE) | 734 | 25.39 (1.23) |
| BPb Q3 (0.91 – 1.36 μg/dL), % (SE) | 712 | 25.00 (0.86) |
| BPb Q4 (>01.36 μg/dL), % (SE) | 785 | 24.86 (1.30) |
| Age Quartile | ||
| Age Q1 (20 - 24 years), % (SE) | 743 | 25.55 (1.40) |
| Age Q2 (25 – 29 years), % (SE) | 669 | 25.78 (1.28) |
| Age Q3 (30 – 34 years), % (SE) | 717 | 22.54 (0.88) |
| Age Q4 (35 – 39 years), % (SE) | 763 | 26.13 (0.89) |